How long can bosutinib be used?

The duration of bosutinib use is usually determined by the doctor based on the patient's specific condition and disease progression. For patients with chronic myelogenous leukemia (CML), bosutinib may require long-term use until sustained good therapeutic effects are achieved. In some cases, doctors may consider tapering the medication once the patient's condition stabilizes, but continue to monitor the patient's condition. The specific time limit for using the drug depends on the stage of the disease, the patient's overall health, and whether adverse reactions occur during treatment. Therefore, patients need to closely cooperate with their doctors’ guidance and receive regular examinations and monitoring while using bosutinib. The exact timing of drug use will vary among individuals, so treatment plans should be individualized and adjusted based on patient response and disease progression.